In another recent study, CD47 has been exploited as part of a long-circulating delivery drug (CRT-CD47-NP-Nec-1s) in the treatment of Alzheimer's disease [76]. The gene discussed is CD47; the disease is early-onset autosomal dominant Alzheimer disease.